Most law firms believe they understand risk.
They assess prospects.
They evaluate merits.
They model likely costs.
They price their time.
But there is one category of risk that is routinely misunderstood, or worse, completely unpriced.
Balance sheet risk.
And that is where litigation funding and ATE insurance fundamentally change the equation.
The Silent Risk Law Firms Carry
When a firm takes on a large contingent or partially contingent matter, three things happen immediately:
- WIP becomes a financing decision.
- Disbursements become capital allocation.
- Adverse costs become an existential exposure.
Even highly profitable firms can distort their cash flow, partner drawings, and growth trajectory by carrying too much contingent inventory.
This is not a legal problem.
It is a capital structure problem.
Yet many firms still treat it as if it were purely about case selection.
Litigation Funding Is Not About “Needing Money”
Sophisticated firms don’t use funding because they are undercapitalised.
They use it because:
- It ring-fences downside risk
- It accelerates portfolio velocity
- It protects partner balance sheets
- It allows simultaneous deployment across multiple high-value matters
In other words, funding converts legal risk into structured financial risk.
That distinction matters.
When properly structured, external capital allows firms to pursue meritorious claims without internally absorbing the volatility of timing, duration, or enforcement uncertainty.
ATE Insurance: The Underutilised Strategic Lever
Many attorneys still view After-the-Event insurance as a defensive tool, something to satisfy a funder or provide comfort to a claimant.
That is far too narrow.
ATE insurance, when used properly:
- De-risks adverse cost exposure
- Strengthens settlement leverage
- Enhances fundability
- Improves portfolio-level return modelling
In larger matters, the presence (or absence) of ATE can materially alter whether capital partners engage at all.
It does not merely reduce risk, it can change the commercial viability of a case.
The Compounding Effect of Duration
One of the most underestimated variables in litigation economics is time.
Duration erodes IRR.
Duration increases capital lock-up.
Duration amplifies enforcement uncertainty.
This is particularly acute in:
- Cross-border enforcement
- Sovereign or quasi-sovereign disputes
- Complex commercial claims with appeal risk
- Large judgment monetisation strategies
Where duration is high, structured funding combined with ATE can materially improve the risk-adjusted return profile.
Firms that understand this do not ask, “Can we win?”
They ask, “How do we optimise the capital architecture around this?”
That is a different level of conversation.
The Strategic Question Firms Should Be Asking
Instead of asking:
“Should we fund this case?”
Consider asking:
“Should this risk sit on our balance sheet at all?”
The most sophisticated firms are not simply using funding opportunistically.
They are using it as a deliberate capital management strategy.
And when funding and ATE are structured early, not retrofitted late, the probability of successful capital engagement increases significantly.
A Practical Takeaway
If you are a partner assessing a large matter, stress-test it through three lenses:
- What is the real downside exposure (including adverse costs)?
- What is the capital lock-up over duration?
- What happens to your internal IRR if enforcement takes twice as long?
If those answers make you uncomfortable, the issue may not be the merits of the case, it may be the absence of structured risk transfer.
If you want to stay up to date with what is going on with ATE insurance and non-recourse litigation funding, Wild Dog serves as a trusted advisor to attorneys and their clients. So stay informed. Stay competitive and subscribe to our Newsletter today.
https://www.linkedin.com/newsletters/wild-dog-litigation-funding-7399383352073654272/